Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily K Sims

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Diabetologia|March 11, 2017
MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cellsEmily K Sims, Alexander J Lakhter, Emily Anderson-Baucum, et al.
Diabetes Care|November 6, 2025
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on TeplizumabChantal Mathieu, Emily K Sims, Lucienne Chatenoud, et al.
Clinical Endocrinology|March 27, 2012
Inhibin B and luteinizing hormone levels in girls aged 6-11 years from NHANES III, 1988-1994Emily K Sims, O Y Addo, Audra L Gollenberg, et al.
Seminars in Immunology|August 29, 2025
Autoimmune diabetes and targets for immunomodulationCamillo Bechi Genzano, Tyla Young, Rachel Bonami, et al.
Laboratory Animals|June 14, 2013
Streptozotocin is equally diabetogenic whether administered to fed or fasted miceZunaira Z Chaudhry, David L Morris, Dan R Moss, et al.
Diabetes|May 20, 2014
Palmitate induces mRNA translation and increases ER protein load in islet β-cells via activation of the mammalian target of rapamycin pathwayMasayuki Hatanaka, Bernhard Maier, Emily K Sims, et al.
Islets|October 15, 2023
Dynamic regulation of pancreatic β cell function and gene expression by the SND1 coregulator <i>in vitro</i>Sukrati Kanojia, Rebecca K Davidson, Jason M Conley, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2024
Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk IndividualsEmily K Sims, David Cuthbertson, Laura Jacobsen, et al.
Diabetologia|February 16, 2018
Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetesAlexander J Lakhter, Rachel E Pratt, Rachel E Moore, et al.
Hormone Research in Paediatrics|July 9, 2026
Screening and monitoring for presymptomatic type 1 diabetes: a time for actionEmily K Sims, Chantal Mathieu, Anette-Gabriele Ziegler, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Diabetologia|March 11, 2017
MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cellsEmily K Sims, Alexander J Lakhter, Emily Anderson-Baucum, et al.
Diabetes Care|November 6, 2025
Toward Disease-Modifying Therapies in Type 1 Diabetes: Focus on TeplizumabChantal Mathieu, Emily K Sims, Lucienne Chatenoud, et al.
Clinical Endocrinology|March 27, 2012
Inhibin B and luteinizing hormone levels in girls aged 6-11 years from NHANES III, 1988-1994Emily K Sims, O Y Addo, Audra L Gollenberg, et al.
Seminars in Immunology|August 29, 2025
Autoimmune diabetes and targets for immunomodulationCamillo Bechi Genzano, Tyla Young, Rachel Bonami, et al.
Laboratory Animals|June 14, 2013
Streptozotocin is equally diabetogenic whether administered to fed or fasted miceZunaira Z Chaudhry, David L Morris, Dan R Moss, et al.
Diabetes|May 20, 2014
Palmitate induces mRNA translation and increases ER protein load in islet β-cells via activation of the mammalian target of rapamycin pathwayMasayuki Hatanaka, Bernhard Maier, Emily K Sims, et al.
Islets|October 15, 2023
Dynamic regulation of pancreatic β cell function and gene expression by the SND1 coregulator <i>in vitro</i>Sukrati Kanojia, Rebecca K Davidson, Jason M Conley, et al.
The Journal of Clinical Endocrinology and Metabolism|January 24, 2024
Comparisons of Metabolic Measures to Predict T1D vs Detect a Preventive Treatment Effect in High-Risk IndividualsEmily K Sims, David Cuthbertson, Laura Jacobsen, et al.
Diabetologia|February 16, 2018
Beta cell extracellular vesicle miR-21-5p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetesAlexander J Lakhter, Rachel E Pratt, Rachel E Moore, et al.
Hormone Research in Paediatrics|July 9, 2026
Screening and monitoring for presymptomatic type 1 diabetes: a time for actionEmily K Sims, Chantal Mathieu, Anette-Gabriele Ziegler, et al.
Pageof 9